Display Settings:

Format

Send to:

Choose Destination
J Neuroimmunol. 2010 Jul 27;224(1-2):108-13. doi: 10.1016/j.jneuroim.2010.05.002.

CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.

Author information

  • 1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.

Abstract

Tumorigenesis requires interactions between tumor progenitors and their microenvironment. We found that low cAMP levels were sufficient for tumorigenesis in a mouse model of Neurofibromatosis-1 (NF1)-associated optic pathway glioma (OPG). We hypothesized that the distinct pattern of glioma in NF1 reflected spatiotemporal differences in CXCL12 effects on cAMP levels. Thus, we sought to alter the pattern of gliomagenesis through manipulation of CXCL12-CXCR4 pathway activation in Nf1 OPG mice. Forced CXCL12 expression induced glioma at a low frequency. Further, treatment of Nf1 OPG mice with AMD3100, a CXCR4 antagonist, did not attenuate glioma growth. Thus, it appears, CXCL12 alone cannot promote gliomagenesis in NF1 mice.

(c) 2010 Elsevier B.V. All rights reserved.

PMID:
20554030
[PubMed - indexed for MEDLINE]
PMCID:
PMC2910179
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk